|
Project Description:
The Consortium’s projects revolve around computational Bioinformatics approaches to harness the human genome to benefit patients with cancer, heart disease, neurodegenerative diseases and AIDS. With the underlying theme of Genes-to-Drugs paradigm, the goals are to transfer the benefits bench research to the patient’s bedside rapidly.
Areas of emphasis:
The scientists at FBRCF are involved in the following aspects of Bioinformatics-based projects:
A. Software/Systems Biology tools development and e-cell models
B. High throughput gene analysis involving microarray and proteome technology and model organism functional genomics approaches
C. Disease gene discovery using Bioinformatics, SNP and personalized medicine
D. Bioinformatics, Drug discovery, validation and optimization
E. Diagnostics and imaging
F. Drug delivery including nanotechnology and DNA chip
Objectives:
The mission of the FBRCF is to establish an interdisciplinary research, education and workforce training in bioinformatics involving a highly proficient group of more than fifty Science and Engineering scientists from
- Academia (FAU, University of Miami, Nova South Eastern University, FIU, KU Leuven, Belgium, Latin American Universities-LA grid)
- Hospitals (Boca Raton Community Hospital)
- Research Institutions (Torrey Pines Institute of Molecular studies, The Scripps Research Institute)
- Industry (IBM).
|